London And Oxford

LONDON and OXFORD, England, August 10, 2011 - Enigma Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today announced that they have signed agreements for the supply and commercialization on an exclusive basis of the Enigma ML system in Europe and other designated key countries, including India, Brazil and Russia.

LONDON and OXFORD, England, March 15, 2010 - Matrix Corporate Capital ("Matrix") and PharmaVentures Limited ("PharmaVentures") today announced the signing of a Memorandum of Understanding ("MOU") covering strategic transactions in the biotech, pharmaceutical and med tech sectors.